Fat cells may inactivate chemotherapeutic drug

(American Association for Cancer Research) Adipocytes, or fat cells, can absorb and metabolize the chemotherapeutic agent daunorubicin, reducing the effectiveness of the drug and potentially contributing to poorer treatment outcomes.